Mast Therapeutics, Inc. (NYSEMKT:MSTX) Files An 8-K Regulation FD Disclosure Market Exclusive By John Harbison|2017-03-06T10:46:19-08:00March 6, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Mast Therapeutics, Inc. (NYSEMKT:MSTX) Files An 8-K Regulation FD Disclosure Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
